Chronic low back pain: Pharmacological, interventional and surgical strategies

Nature Reviews Neurology

Volumn 9, Issue 8, 2013, Pages 462-473

  Morlion, Bart ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BUPRENORPHINE; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DULOXETINE; ESCITALOPRAM; ESOMEPRAZOLE; GABAPENTIN; IBUPROFEN; LOCAL ANESTHETIC AGENT; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OPIATE DERIVATIVE; OXYCODONE; PARACETAMOL; PLACEBO; PREGABALIN; STEROID; TAPENTADOL; TETRAZEPAM;

ANALGESIA; ANDROGEN DEFICIENCY; ARTHRALGIA; BEHAVIOR THERAPY; BIOMECHANICS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ASSESSMENT; CONSTIPATION; DIABETIC NEUROPATHY; DIZZINESS; DRUG COST; DRUG FATALITY; FIBROMYALGIA; FRACTURE; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOGONADISM; INFERTILITY; KIDNEY DISEASE; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TOXICITY; LOW BACK PAIN; LOW DRUG DOSE; MUSCULOSKELETAL PAIN; NAUSEA; NEUROPATHIC PAIN; OSTEOPOROSIS; PATIENT CARE; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SPINE SURGERY; SYSTEMIC DISEASE; TREATMENT FAILURE;

CHRONIC DISEASE; HUMANS; LOW BACK PAIN; PAIN MANAGEMENT;

EID: 84881371897     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.130     Document Type: Review

References (125)

1. Nielens, H. et al. Chronic low back pain. Belgian Health Care Knowledge Centre (KCE) [online], https://kce.fgov.be/sites/default/files/page-documents/ d20061027371.pdf (2006
2. Airaksinen. O. et al., European guidelines for the management of chronic nonspecific low back pain. Eur. Spine J. 15 (Suppl. 2), S192-S300 (2006
3. Walker, B. F. The prevalence of low back pain: A systematic review of the literature from 1966 to 1998. J. Spinal Disord. 13, 205-217 (2000
4. Freburger, J. K. et al. The rising prevalence of chronic low back pain. Arch. Intern. Med. 169, 251-258 (2009
5. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. (Institute for Health Metrics and Evaluation, 2013
6. Vos, T. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-2196 (2013
7. Deyo, R. A., Mirza, S. K. & Martin, B. I. Back pain prevalence and visit rates: Estimates from U.S. national surveys, 2002. Spine 31, 2724-2727 (2006
8. Neuhauser, H., Ellert, U. & Ziese, T. Chronic back pain in the general population in Germany 2002/2003: Prevalence and highly affected population groups [German]. Gesundheitswesen 67, 685-693 (2005
9. Webb, R. et al. Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine 28, 1195-1202 (2003
10. Verbunt, J. A., Smeets, R. J. & Wittink, H. M. Cause or effect? Deconditioning and chronic low back pain. Pain 149, 428-430 (2010
11. Nordeman, L., Gunnarsson, R. & Mannerkorpi, K. Prevalence and characteristics of widespread pain in female primary health care patients with chronic low back pain. Clin. J. Pain. 28, 65-72 (2012
12. Adamson, J., Hunt, K. & Nazareth, I. The influence of socio-demographic characteristics on consultation for back pain- a review of the literature. Fam. Pract. 28, 163-171 (2011
13. van Tulder. et al. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur. Spine J. 15 (Suppl. 2), S169-S191 (2006
14. Croft, P. R., Macfarlane, G. J., Papageorgiou, A. C., Thomas, E. & Silman, A. J. Outcome of low back pain in general practice: A prospective study. BMJ 316, 1356-1359 (1998
15. Andersson, G. B. Epidemiological features of chronic low-back pain. Lancet 354, 581-585 (1999
16. Itz, C. J., Geurts, J. W., van Kleef, M. & Nelemans, P. Clinical course of non-specific low back pain: A systematic review of prospective cohort studies set in primary care. Eur. J. Pain 17, 5-15 (2013
17. Woolf, C. J. What is this thing called pain? J. Clin. Invest. 120, 3742-3744 (2010
18. Treede, R. D. et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70, 1630-1635 (2008
19. Morlion, B. Pharmacotherapy of low back pain: Targeting nociceptive and neuropathic pain components. Curr. Med. Res. Opin. 27, 11-33 (2011
20. Cohen, S. P., Argoff, C. E. & Carragee, E. J. Management of low back pain. BMJ 337, 100-106 (2008
21. Deyo, R. A. & Weinstein, J. N. Low back pain. N. Engl. J. Med. 344, 363-370 (2001
22. Freynhagen, R. & Baron, R. The evaluation of neuropathic components in low back pain. Curr. Pain Headache Rep. 13, 185-190 (2009
23. Balague, F., Mannion, A. F., Pellise, F. & Cedraschi, C. Non-specific low back pain. Lancet 379, 482-491 (2012
24. Dagenais, S., Tricco, A. C. & Haldeman, S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J. 10, 514-529 (2010
25. Nicholas, M. K., Linton, S. J., Watson, P. J., Main, C. J. & "Decade of the Flags" Working Group. Early identification and management of psychological risk factors ("yellow flags") in patients with low back pain: A reappraisal. Phys. Ther. 91, 737-753 (2011
26. Chou, R & Shekelle, P. Will this patient develop persistent disabling low back pain? JAMA 303, 1295-1302 (2010
27. Chou, R., Fu, R., Carrino, J. A. & Deyo, R. A. Imaging strategies for low-back pain: Systematic review and meta-analysis. Lancet 373, 463-472 (2009
28. Nachemson, A. A critical look at the treatment for low back pain. Scand. J. Rehabil. Med. 11, 143-147 (1979
29. Johnson, E. W. Pain generator. Am. J. Phys. Med. Rehabil. 79, 411 (2000
30. Pradhan, B., Brox, J. I. & Indahl, A. in Evidence-Based Management of Low Back Pain (eds Dagenais, S. & Haldeman, S.) 55-72 (Elsevier Mosby, 2012
31. Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N. & Turk, D. C. The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychol. Bull. 133, 581-624 (2007
32. Waddell, G. Biopsychosocial analysis of low back pain. Baillieres Clin. Rheumatol. 6, 523-557 (1992
33. Vlaeyen, J. W. & Linton, S. J. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 85, 317-332 (2000
34. Haldeman, S. & Dagenais, S. A supermarket approach to the evidence-informed management of chronic low back pain. Spine J. 8, 1-7 (2008
35. Wolfe, F. & Hauser, W. Fibromyalgia diagnosis and diagnostic criteria. Ann. Med. 43, 495-502 (2011
36. Lapossy, E., Maleitzke, R., Hrycaj, P., Mennet, W. & Muller, W. The frequency of transition of chronic low back pain to fibromyalgia. Scand. J. Rheumatol. 24, 29-33 (1995
37. Kindler, L. L., Jones, K. D., Perrin, N. & Bennett, R. M. Risk factors predicting the development of widespread pain from chronic back or neck pain. J. Pain. 11, 1320-1328 (2010
38. Savigny, P., Watson, P. & Underwood, M. Early management of persistent non-specific low back pain: Summary of NICE guidance. BMJ 338, 1441-1445 (2009
39. Chou, R. et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann. Intern. Med. 147, 478-491 (2007
40. Manchikanti, L et al. Guidelines warfare over interventional techniques: Is there a lack of discourse or straw man? Pain Physician 15, E1-E26 (2012
41. Boswell, M., Abdi, S. & Manchikanti, L. Misinterpretation of evidence synthesis and ASIPP guidelines by Chou. Pain Med. 10, 422-424 (2009
42. Manchikanti, L. et al. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 1. Diagnostic interventions. Pain Physician 13, E141-E174 (2010
43. Keller, A., Hayden, J., Bombardier, C. & van Tulder, M. Effect sizes of non-surgical treatments of non-specific low-back pain. Eur. Spine J. 16, 1776-1788 (2007
44. Carey, T. S. et al. A long way to go: Practice patterns and evidence in chronic low back pain care. Spine 34, 718-724 (2009
45. Reese, C. & Mittag, O. Psychological interventions in the rehabilitation of patients with chronic low back pain: Evidence and recommendations from systematic reviews and guidelines. Int. J. Rehabil. Res. 36, 6-12 (2013
46. Henschke, N. et al. Behavioural treatment for chronic low-back pain. Cochrane Database of Systematic Reviews, Issue 7. Art. No.:CD002014. http://dx.doi.org/10.1002/14651858.CD002014.pub3.
47. Turk, D. C., Wilson, H. D. & Cahana, A. Treatment of chronic non-cancer pain. Lancet 377, 2226-2235 (2011
48. van Tulder, M., Malmivaara, A., Esmail, R. & Koes, B. Exercise therapy for low back pain: A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 25, 2784-2796 (2000
49. Koes, B. W., van Tulder, M. W., Ostelo, R., Kim Burton, A. & Waddell, G. Clinical guidelines for the management of low back pain in primary care: An international comparison. Spine 26, 2504-2513 (2001
50. Davies, R. A., Maher, C. G. & Hancock, M. J. A systematic review of paracetamol for non-specific low back pain. Eur. Spine J. 17, 1423-1430 (2008
51. Williams, C. M. et al. PACE-the first placebo controlled trial of paracetamol for acute low back pain: Design of a randomised controlled trial. BMC Musculoskelet. Disord. 11, 169 (2010
52. Holt, M. & Ju, C. Drug-induced liver injury. Handb. Exp. Pharmacol. 196, 3-27 (2010
53. Kuehn, B. M. FDA focuses on drugs and liver damage: Labeling and other changes for acetaminophen. JAMA 302, 369-371 (2009
54. Roelofs, P. D., Deyo, R. A., Koes, B. W., Scholten, R. J. & van Tulder, M. W. Nonsteroidal anti-inflammatory drugs for low back pain: An updated Cochrane review. Spine 33, 1766-1774 (2008
55. van Tulder, M. W., Scholten, R. J., Koes, B. W. & Deyo, R. A. Nonsteroidal anti-inflammatory drugs for low back pain: A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 25, 2501-2513 (2000
56. McGettigan, P. & Henry, D. Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296, 1633-1644 (2006
57. McGettigan, P. & Henry, D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies. PLoS Med. 8, e1001098 (2011
58. Whelton, A. Renal and related cardiovascular effects of conventional and COX 2 specific NSAIDs and non-NSAID analgesics. Am. J. Ther. 7, 63-74 (2000
59. Bessone, F Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J. Gastroenterol. 16, 5651-5661 (2010
60. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J. Am. Geriatr. Soc. 57, 1331-1346 (2009
61. Henry, D. et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. BMJ 312, 1563-1566 (1996
62. Roubille, C., Martel-Pelletier, J., Davy, J. M., Haraoui, B. & Pelletier, J. P. Cardiovascular adverse effects of anti-inflammatory drugs. Antiinflamm. Antiallergy Agents Med. Chem. 12, 55-67 (2012
63. Pinto, A., Farrar, J. T. & Hersh, E. V. Prescribing NSAIDs to patients on SSRIs: Possible adverse drug interaction of importance to dental practitioners. In Compend. Contin. Educ. Dent. 30, 142-151 (1995
64. Farkouh, M. E. et al. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann. Rheum. Dis. 66, 764-770 (2007
65. Cheetham, T. C., Levy, G., Niu, F. & Bixler, F. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase 2 inhibitors in patients on warfarin. Ann. Pharmacother. 43, 1765-1773 (2009
66. Mackenzie, I. S., Coughtrie, M. W., MacDonald, T. M. & Wei, L. Antiplatelet drug interactions. J. Intern. Med. 268, 516-529 (2010
67. de Leon-Casasola, O. A. Opioids for chronic pain: New evidence, new strategies, safe prescribing. Am. J. Med. 126, S3-S11 (2013
68. Baldini, A., Von Korff, M. & Lin, E. H. A review of potential adverse effects of long-term opioid therapy: A practitioner's guide. Prim. Care Companion CNS Disord. 14, pii: PCC.11m01326 (2012
69. Gomes, T., Mamdani, M. M., Dhalla, I. A., Paterson, J. M. & Juurlink, D. N. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch. Intern. Med. 171, 686-691 (2011
70. Chou, R. & Huffman, L. H. Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann. Intern. Med. 147, 505-514 (2007
71. Steiner, D., Munera, C., Hale, M., Ripa, S. & Landau, C. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: A randomized, double-blind study. J. Pain 12, 1163-1173 (2011
72. Yarlas, A. et al. A randomized, placebo-controlled study of the impact of the 7 day buprenorphine transdermal system on health-related quality of life in opioid-naive patients with moderate to severe chronic low back pain. J. Pain 14, 14-23 (2013
73. Wild, J. E. et al. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract. 10, 416-427 (2010
74. Buynak, R. et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: Results of a prospective, randomized, double-blind, placebo- and active-controlled phase III study. Expert Opin. Pharmacother. 11, 1787-1804 (2010
75. Afilalo, M. & Morlion, B. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Pain Physician 16, 27-40 (2013
76. Pergolizzi, J et al. Tapentadol in the management of chronic low back pain: A novel approach to a complex condition? J. Pain Res. 4, 1-8 (2011
77. Chou, R., Atlas, S. J., Stanos, S. P. & Rosenquist, R. W. Nonsurgical interventional therapies for low back pain: A review of the evidence for an American Pain Society clinical practice guideline. Spine 34, 1078-1093 (2009
78. Finnerup, N. B., Sindrup, S. H. & Jensen, T. S. The evidence for pharmacological treatment of neuropathic pain. Pain 150, 573-581 (2010
79. Skljarevski, V. et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine 35, E578-E585 (2010
80. Skljarevski, V. et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur. J. Neurol. 16, 1041-1048 (2009
81. Skljarevski, V. et al. Duloxetine versus placebo in patients with chronic low back pain: A 12-week, fixed-dose, randomized, double-blind trial. J. Pain 11, 1282-1290 (2010
82. Mazza, M., Mazza, O., Pazzaglia, C., Padua, L. & Mazza, S. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin. Pharmacother. 11, 1049-1052 (2010
83. Highlights of prescribing information. FDA [online], http://www. accessdata.fda.gov/drugsatfda-docs/label/2012/021427s040s041lbl.pdf (2013
84. Manchikanti, L., Pampati, V., Falco, F. J. & Hirsch, J. A. Growth of spinal interventional pain management techniques: Analysis of utilization trends and Medicare expenditures 2000 to 2008. Spine 2, 157-168 (2012
85. American Society of Anesthesiologists Task Force on Chronic Pain Management; American Society of Regional Anesthesia and Pain Medicine. Practice guidelines for chronic pain management: An updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology 112, 810-833 (2010
86. Manchikanti, L. et al. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 13, E215-E264 (2010
87. van Tulder, M. W., Koes, B., Seitsalo, S. & Malmivaara, A. Outcome of invasive treatment modalities on back pain and sciatica: An evidence-based review. Eur. Spine J. 15 (Suppl. 1), S82-S92 (2006
88. Chou, R., Atlas, S J., Loeser, J. D., Rosenquist, R. W. & Stanos, S. P. Guideline warfare over interventional therapies for low back pain: Can we raise the level of discourse? J. Pain 12, 833-839 (2011
89. Chou, R. et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: An evidence-based clinical practice guideline from the American Pain Society. Spine 34, 1066-1077 (2009
90. The British Pain Society. The NICE Back Pain Issue The controversy discussed. The British Pain Society [online], http://www.britishpainsociety.org/ bps-nl-autumn-2009.pdf (2009
91. van Kleef, M., Mekhail, N. & van Zundert, J. Evidence-based guidelines for interventional pain medicine according to clinical diagnoses. Pain Pract. 9, 247-251 (2009
92. Guyatt, G. et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an american college of chest physicians task force. Chest 129, 174-181 (2006
93. Van Boxem, K., Cahana, A. & Van Zundert, J. Injection therapy and denervation procedures for chronic low back pain: A systematic review-clinical value? Eur. Spine J. 5, 820-821 (2011
94. Carragee, E. J. et al. 2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: A ten-year matched cohort study. Spine 34, 2338-2345 (2009
95. Beresford, Z. M., Kendall, R. W. & Willick, S. E. Lumbar facet syndromes. Curr. Sports Med. Rep. 9, 50-56 (2010
96. Chan, C. W. & Peng, P. Failed back surgery syndrome. Pain Med. 12, 577-606 (2011
97. Cohen, S. P., Huang, J. H. & Brummett, C. Facet joint pain-advances in patient selection and treatment. Nat. Rev. Rheumatol. 9, 101-116 (2013
98. Cohen, S. P. et al. Establishing an optimal "cutoff" threshold for diagnostic lumbar facet blocks: A prospective correlational study. Clin. J. Pain 29, 382-391 (2013
99. Armon, C., Argoff, C. E., Samuels J., Backonja, M. M. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 68, 723-729 (2007
100. Manchikanti, L. et al. Effectiveness of therapeutic lumbar transforaminal epidural steroid injections in managing lumbar spinal pain. Pain Physician 15, E199-E245 (2012
101. Deyo, R. A. et al. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 303, 1259-1265 (2010
102. Weinstein, J. N., Lurie, J. D., Olson, P. R., Bronner, K. K. & Fisher, E. S. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine 31, 2707-2714 (2006
103. Gibson, J. N. & Waddell, G. Surgical interventions for lumbar disc prolapse: Updated Cochrane Review. Spine 32, 1735-1747 (2007
104. Gibson, J. N. & Waddell, G. Surgery for degenerative lumbar spondylosis: Updated Cochrane Review. Spine 30, 2312-2320 (2005
105. Smith, Z. A. & Fessler, R. G. Paradigm changes in spine surgery-evolution of minimally invasive techniques. Nat. Rev. Neurol. 8, 443-450 (2012
106. Froholdt, A., Reikeraas, O., Holm, I., Keller, A. & Brox, J. I. No difference in 9 year outcome in CLBP patients randomized to lumbar fusion versus cognitive intervention and exercises. Eur. Spine J. 21, 2531-2538 (2012
107. Phillips, F. M., Slosar, P. J., Youssef, J. A., Andersson, G. & Papatheofanis, F. Lumbar spine fusion for chronic low back pain due to degenerative disc disease: A systematic review. Spine 38, E409-E422 (2013
108. Willems, P. C., Staal, J. B., Walenkamp, G. H. & de Bie, R. A. Spinal fusion for chronic low back pain: Systematic review on the accuracy of tests for patient selection. Spine J. 13, 99-109 (2013
109. North, R. B. et al. Failed back surgery syndrome: 5 year follow-up in 102 patients undergoing repeated operation. Neurosurgery 28, 685-690 (1991
110. Simpson, E. L., Duenas, A., Holmes, M. W., Papaioannou, D. & Chilcott, J. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: Systematic review and economic evaluation. Health Technol. Assess. 13, 1-154 (2009
111. Freynhagen, R. et al. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: A prospective observational pilot study (MIPORT). Curr. Med. Res. Opin. 22, 529-537 (2006
112. Wang, H., Schiltenwolf, M. & Buchner, M. The role of TNF-alpha in patients with chronic low back pain - a prospective comparative longitudinal study. Clin. J. Pain 24, 273-278 (2008
113. Yamauchi, K. et al. Nerve growth factor of cultured medium extracted from human degenerative nucleus pulposus promotes sensory nerve growth and induces substance p in vitro. Spine 34, 2263-2269 (2009
114. Katz, N. et al. Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain 152, 2248-2258 (2011
115. Korhonen, T. et al. The treatment of disc herniation induced sciatica with infliximab: One-year follow-up results of FIRST II, a randomized controlled trial. Spine 31, 2759-2766 (2006
116. Ohtori, S. et al. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: A prospective randomized study. Spine 37, 439-444 (2012
117. Freynhagen, R., Baron, R., Gockel, U. & Tolle, T. R. painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin. 22, 1911-1920 (2006
118. O'Connor, A. B. Neuropathic pain: Quality of life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 27, 95-112 (2009
119. Schmidt, C. O. et al. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur. J. Pain 13, 1030-1035 (2009
120. Shaw, W. S., Main, C. J. & Johnston, V. Addressing occupational factors in the management of low back pain: Implications for physical therapist practice. Phys. Ther. 91, 777-789 (2011
121. Rozenberg, S., Foltz, V. & Fautrel, B. Treatment strategy for chronic low back pain. Joint Bone Spine 79, 555-559 (2012
122. Van Boxem, K. et al. 11. Lumbosacral radicular pain. Pain Pract. 10, 339-358 (2010
123. van Kleef, M. et al. 12. Pain originating from the lumbar facet joints. Pain Pract. 10, 459-469 (2010
124. Vanelderen, P. et al. 13. Sacroiliac joint pain. Pain Pract. 10, 470-478 (2010
125. Kallewaard, J. W. et al. 15. Discogenic low back pain. Pain Pract. 10, 560-579 (2010